Brochure atelier IDM-AVC - ISQUA 2010

Has

Sujets

• Médecine

Informations

• Publié par: haute-autorite-sante
• Nombre de lectures: 22
• Licence : En savoir +
  Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique
• Langue: Français

Extrait

90 Minutes

10 Minutes

10 Minutes

15 Minutes

10 Minutes

15 Minutes

Wednesday, 13thOctober 2010

Track 9
Measurement and Outcomes

Improving patient outcomes through
integrated care pathways for stroke and
myocardial infarction – International
experiences

Chair : Niek KLAZINGA

The state of art of integrated care pathways for stroke
Turgut Tatlisumak

The state of art of integrated care pathways for myocardial infarction
Nicolas Danchin

Efficiency, safety and access clinical indicators of pathways for stroke
and myocardial infarction, results of the Rhône-Alpes region
Armelle Desplanques-Leperre, Carlos El Khoury


Clinical pathway of patients with stroke in China
Yicheng Zhu

Clinical urgent pathways of patients with stroke and myocardial
infarction in the USA ; the point of view of health policy and clinician
experts
David Ballard, Brett Stauffer

Improving patient outcomes through
integrated care pathways for stroke
and myocardial infarction:
international experiences

Wednesday, 13thOctober 2010

Improving patient outcomes through integrated care
pathways for stroke and myocardial infarction:
international experiences

 
    
 
  
  

!"!#$%"$

Cardiovascular diseases are the number one cause of death in developed countries.
Every year, an estimated 17 million people globally die of it, particularly of
myocardial infarctions and strokes.

Myocardial infarction and stroke are both requiring urgent therapy, and then
adapted rehabilitation and secondary prevention.

Worldwide, integrated care pathways have been set u p to improve myocardial
infarction and stroke management and to allow for better patient outcomes in terms
of survival and recovery.

Let’s discuss these major public health issues:

 How are optimal care pathways within different health systems organized?

 insure prompt access to the optimal care pathway for all eligibleHow to
patients?

 What is the role of the patient?





Which quality measures can be defined?

What clinical impact can be expected from these care pathways?

 
&'  $
! (  &
)* )

$"'!%"






 
 $   
&'  $
+$ '& &
  

"%$&"&&&"




  
'$ ,
&'
ô &  $
 &
-  

 !"%"

 !"#
!
 $' 
'& &'
   
./
  

"&0%"

$% 
&'  $
!$ ( , $ &1   '  , 
23+  

#456% "'"

& ''
   
,7&1
2   '
)) (

2"%8"

() *+ &
 -    1
 1 2&